| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Begum Yetis Sayin, Ali Ot. Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options. Cardiology and therapy. 2022-03-30. PMID:35353354. |
in this review we systematically summarize treatments for the different patterns of cardiac hypertrophy and their impacts on outcomes while informing clinicians on advances in the treatment of lvh due to fabry disease, cardiac amyloidosis, and hypertrophic cardiomyopathy. |
2022-03-30 |
2023-08-13 |
Not clear |
| Shaimaa A Fadl, Jonathan W Revels, Leila Rezai Gharai, Kate Hanneman, Franklin Dana, Elizabeth Kate Proffitt, John D Grizzar. Cardiac MRI of Hereditary Cardiomyopathy. Radiographics : a review publication of the Radiological Society of North America, Inc. 2022-03-11. PMID:35275782. |
it clearly shows regions of asymmetric wall thickening that are typical of hypertrophic cardiomyopathy and allows it to be differentiated from other hereditary disorders such as fabry disease or transthyretin cardiac amyloidosis that produce concentric hypertrophy. |
2022-03-11 |
2023-08-13 |
Not clear |
| Shaimaa A Fadl, Jonathan W Revels, Leila Rezai Gharai, Kate Hanneman, Franklin Dana, Elizabeth Kate Proffitt, John D Grizzar. Cardiac MRI of Hereditary Cardiomyopathy. Radiographics : a review publication of the Radiological Society of North America, Inc. 2022-03-11. PMID:35275782. |
late gadolinium enhancement provides a different tissue property and allows these latter two causes of concentric hypertrophy to be distinguished on the basis of their enhancement appearances (fabry disease shows midwall basal inferolateral enhancement, and amyloidosis shows global subendocardial enhancement). |
2022-03-11 |
2023-08-13 |
Not clear |
| Piotr Gościniak, Tomasz Baron, Sławomir Milczarek, Magdalena Kostkiewicz, Bogusław Machalińsk. Updates for the diagnosis and management of cardiac amyloidosis. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2022-02-23. PMID:35195962. |
the differential diagnosis of the causes of myocardial hypertrophy includes arterial hypertension, hypertrophic cardiomyopathy, aortic stenosis (as), athletic heart syndrome, fabry disease, and cardiac amyloidosis (ca). |
2022-02-23 |
2023-08-13 |
Not clear |
| Chung-Lin Lee, Shuan-Pei Lin, Dau-Ming Niu, Hsiang-Yu Li. Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) Improvement: A Review and Meta-Analysis. International journal of medical sciences. vol 19. issue 1. 2022-01-03. PMID:34975306. |
fabry disease and the effectiveness of enzyme replacement therapy (ert) in left ventricular hypertrophy (lvh) improvement: a review and meta-analysis. |
2022-01-03 |
2023-08-13 |
Not clear |
| Marijana Tadic, Cesare Cuspidi, Sven Plein, Isidora Grozdic Milivojevic, Dao Wen Wang, Guido Grassi, Giuseppe Manci. Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus. Heart failure reviews. vol 26. issue 6. 2021-12-01. PMID:32170529. |
furthermore, cmr can provide differentiation of lvh between hypertensive patients and cardiomyopathies (hypertrophic or fabry disease). |
2021-12-01 |
2023-08-13 |
Not clear |
| Kenji Onoue, Yoshihiko Sait. New treatment for myocardial diseases. Journal of cardiology. vol 77. issue 6. 2021-11-24. PMID:33250269. |
this article outlines the mechanism of action and clinical data of novel therapeutic agents specific for myocardial diseases such as dilated cardiomyopathy, hypertrophic cardiomyopathy, fabry disease, cardiac amyloidosis, and myocarditis. |
2021-11-24 |
2023-08-13 |
Not clear |
| Dominique P Germain, Sergey Moiseev, Fernando Suárez-Obando, Faisal Al Ismaili, Huda Al Khawaja, Gheona Altarescu, Fellype C Barreto, Farid Haddoum, Fatemeh Hadipour, Irina Maksimova, Mirelle Kramis, Sheela Nampoothiri, Khanh Ngoc Nguyen, Dau-Ming Niu, Juan Politei, Long-Sun Ro, Dung Vu Chi, Nan Chen, Sergey Kutse. The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry disease. Molecular genetics & genomic medicine. vol 9. issue 5. 2021-10-29. PMID:33835733. |
newborn screening and screening of at-risk populations, (e.g., patients with hypertrophic cardiomyopathy or undiagnosed nephropathies) can identify individuals with fabry disease. |
2021-10-29 |
2023-08-13 |
Not clear |
| Hidekazu Tanak. Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain. Journal of echocardiography. vol 19. issue 2. 2021-10-28. PMID:33460030. |
it is commonly detected in athletes, arterial hypertension, aortic stenosis, hypertrophic cardiomyopathy, cardiac amyloidosis, fabry disease, or friedreich's ataxia. |
2021-10-28 |
2023-08-13 |
Not clear |
| Hideki Fujii, Keiji Kono, Tetsushi Yamamoto, Tetsuari Onishi, Shunsuke Goto, Kentaro Nakai, Hiroya Kawai, Ken-Ichi Hirata, Masafumi Fukagawa, Shinichi Nish. Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease. Clinical kidney journal. vol 5. issue 6. 2021-10-21. PMID:24976967. |
effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with fabry disease. |
2021-10-21 |
2023-08-13 |
Not clear |
| Yan Xiao, Yang Sun, Tao Tian, Tian-Jie Wang, Ran-Xu Zhao, Ying Zhang, Lin-Ping Wang, Ya-Xin Liu, Chao-Xia Lu, Xian-Liang Zhou, Wei-Xian Yan. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy. The American journal of the medical sciences. vol 362. issue 3. 2021-10-18. PMID:34266644. |
prevalence and clinical characteristics of fabry disease in chinese patients with hypertrophic cardiomyopathy. |
2021-10-18 |
2023-08-13 |
Not clear |
| Yan Xiao, Yang Sun, Tao Tian, Tian-Jie Wang, Ran-Xu Zhao, Ying Zhang, Lin-Ping Wang, Ya-Xin Liu, Chao-Xia Lu, Xian-Liang Zhou, Wei-Xian Yan. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy. The American journal of the medical sciences. vol 362. issue 3. 2021-10-18. PMID:34266644. |
the prevalence of fabry disease (fd) in chinese patients with hypertrophic cardiomyopathy (hcm) is unclear. |
2021-10-18 |
2023-08-13 |
Not clear |
| Sam Williams, Ahmed El-Medany, Angus Nightingale, Yasmin Ismai. Rare presentation of Fabry disease as 'burnt-out' hypertrophic cardiomyopathy. BMJ case reports. vol 14. issue 9. 2021-09-07. PMID:34479887. |
rare presentation of fabry disease as 'burnt-out' hypertrophic cardiomyopathy. |
2021-09-07 |
2023-08-13 |
Not clear |
| Maheedhar Gedela, Rakshya Sharma, Kristin DeBerg, Christopher Stanto. Application of Genetic Testing in Unveiling the Diagnosis of Fabry Disease in a Patient with Hypertrophic Cardiomyopathy. South Dakota medicine : the journal of the South Dakota State Medical Association. vol 74. issue 4. 2021-08-27. PMID:34432960. |
application of genetic testing in unveiling the diagnosis of fabry disease in a patient with hypertrophic cardiomyopathy. |
2021-08-27 |
2023-08-13 |
Not clear |
| Costantina Prota, Donatella Ferraioli, Giuseppe Iuliano, Martina Pucci, Ilaria Radano, Pompea Bottiglieri, Valentina Favalli, Federico Pieruzzi, Gennaro Galasso, Carmine Vecchione, Rodolfo Citr. A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients. Journal of cardiovascular medicine (Hagerstown, Md.). vol 22. issue 1. 2021-08-17. PMID:33283995. |
a novel missense mutation for fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients. |
2021-08-17 |
2023-08-13 |
Not clear |
| Yüksel Çavuşoğlu, Ebru Özpelit, Nur Arslan, Mesut Demir, Gökhan Kahveci, Hüseyin Onay, Emir Özgür Barış Ökçün, Omaç Tufekcioglu, Selcen Yakar Tülüce, Gonca Kılıç Yıldırı. [Fabry disease in cardiology: Diagnosis and therapeutic approaches]. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. vol 48. issue Suppl 2. 2021-08-09. PMID:33476309. |
however, in clinical practice, ventricular hypertrophy is usually thought to be due to hypertrophic cardiomyopathy in the absence of hypertension or aortic stenosis and fabry disease is often undiagnosed or overlooked. |
2021-08-09 |
2023-08-13 |
Not clear |
| João B Augusto, Nicolas Johner, Dipen Shah, Sabrina Nordin, Kristopher D Knott, Stefania Rosmini, Clement Lau, Mashael Alfarih, Rebecca Hughes, Andreas Seraphim, Ravi Vijapurapu, Anish Bhuva, Linda Lin, Natalia Ojrzyńska, Tarekegn Geberhiwot, Gabriella Captur, Uma Ramaswami, Richard P Steeds, Rebecca Kozor, Derralynn Hughes, James C Moon, Mehdi Namda. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage. European heart journal. Cardiovascular Imaging. vol 22. issue 7. 2021-08-05. PMID:32514567. |
cardiac involvement in fabry disease (fd) occurs prior to left ventricular hypertrophy (lvh) and is characterized by low myocardial native t1 with sphingolipid storage reflected by cardiovascular magnetic resonance (cmr) and electrocardiogram (ecg) changes. |
2021-08-05 |
2023-08-13 |
Not clear |
| Francesca Graziani, Rosa Lillo, Elena Panaioli, Gionata Spagnoletti, Maurizio Pieroni, Paolo Ferrazzi, Antonia Camporeale, Elena Verrecchia, Ludovico Luca Sicignano, Raffaele Manna, Filippo Cre. Evidence of evolution towards left midventricular obstruction in severe Anderson-Fabry cardiomyopathy. ESC heart failure. vol 8. issue 1. 2021-07-01. PMID:33211404. |
in our population of patients with fabry disease and severe left ventricular hypertrophy (lvh) at the time of diagnosis, we observed an evolution towards a midventricular obstructive phenotype. |
2021-07-01 |
2023-08-13 |
Not clear |
| Cristina Chimenti, Romina Verardo, Andrea Frustac. Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease. Orphanet journal of rare diseases. vol 16. issue 1. 2021-06-28. PMID:33838691. |
hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with fabry disease. |
2021-06-28 |
2023-08-13 |
Not clear |
| Mustafa Yenerçağ, Uğur Arsla. Tp-e interval and Tp-e/QT ratio and their association with left ventricular diastolic dysfunction in Fabry disease without left ventricular hypertrophy. Journal of electrocardiology. vol 59. 2021-06-21. PMID:31945689. |
tp-e interval and tp-e/qt ratio and their association with left ventricular diastolic dysfunction in fabry disease without left ventricular hypertrophy. |
2021-06-21 |
2023-08-13 |
Not clear |